polatuzumab vedotin,axicabtagene ciloleucel,lisocabtagene maraleucel
gilead,roche,bms,daiichi sankyo
['zuma-7', 'transform,(-transformi),(-transforme),(-transforma),(-transforms),(-transform1),(-transform 1),(-transform-1),(-transform2),(-transform 2),(-transform-2)', ' pola ', 'dlbcl']
results of pola-rice as presented today #ash22 
Heme/Onc; NHL/HL/CLL; economics in med. Adj Professor U South Carolina; Leadership/Strategy. Host: the #HealthcareUnfiltered Podcast. https://t.co/bsOxNVWWLZ